1. Cholangiocarcinoma — evolving concepts and therapeutic strategies;Rizvi;Nat Rev Clin Oncol,2018
2. Cholangiocarcinoma 2020: the next horizon in mechanisms and management;Banales;Nat Rev Gastroenterol Hepatol,2020
3. Cholangiocarcinoma;Brindley;Nat Rev Dis Primers,2021
4. Addition of ramucirumab or merestinib to standard first-line chemotherapy for locally advanced or metastatic biliary tract cancer: a randomised, double-blind, multicentre, phase 2 study;Valle;Lancet Oncol,2021
5. Gemcitabine and cisplatin plus durvalumab with or without tremelimumab in chemotherapy-naive patients with advanced biliary tract cancer: an open-label, single-centre, phase 2 study;Oh;Lancet Gastroenterol Hepatol,2022